BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tominaga K, Kamimura K, Sato H, Ko M, Kawata Y, Mizusawa T, Yokoyama J, Terai S. Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status. World J Clin Cases 2020; 8(11): 2092-2101 [PMID: 32548138 DOI: 10.12998/wjcc.v8.i11.2092]
URL: https://www.wjgnet.com/2218-6190/full/v8/i11/2092.htm
Number Citing Articles
1
Laura Gnesotto, Guido Mioso, Mauro Alaibac. Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)Experimental and Therapeutic Medicine 2022; 24(2) doi: 10.3892/etm.2022.11463
2
Munenori Kawai, Chiharu Kawanami, Akihisa Fukuda, Hiroshi Seno. Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroidsClinical Journal of Gastroenterology 2021; 14(5): 1561 doi: 10.1007/s12328-021-01460-0
3
Kazue HARADA, Naoko SHIMOMURA, Hiroko SUGIMOTO, Shinichi HASHIMOTO, Yutaka SHIMOMURA. A Case of Pyoderma Gangrenosum Complicated with Ulcerative Colitis Successfully Treated by Granulocyte and Monocyte Adsorption ApheresisNishi Nihon Hifuka 2022; 84(2): 110 doi: 10.2336/nishinihonhifu.84.110
4
Toshiyuki Yamamoto, Kenshi Yamasaki, Keiichi Yamanaka, Mayumi Komine, Tamihiro Kawakami, Osamu Yamamoto, Takuro Kanekura, Tetsuya Higuchi, Toshiya Takahashi, Yoshiaki Matsushima, Nobuyuki Kikuchi. Clinical guidance of pyoderma gangrenosum 2022The Journal of Dermatology 2023; 50(9) doi: 10.1111/1346-8138.16845